Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


May 03, 2015 11:43 PM ET

Biotechnology

Company Overview of Alkermes plc

Executive Profile

Wendy L. Dixon Ph.D.

Director and Chairman of Nominating & Corporate Governance Committee, Alkermes plc
AgeTotal Calculated CompensationThis person is connected to 8 Board Members in 8 different organizations across 10 different industries.

See Board Relationships
59$558,393

Background

Dr. Wendy L. Dixon, Ph.D., served as the Chief Marketing Officer and President of Global Marketing at Worldwide Medicines Pharmaceuticals Group, a division of Bristol-Myers Squibb Company from December 2001 to May 2009. Dr. Dixon was responsible for leading Global Marketing to commercialize new products and to determine the lifecycle strategy of the in-line growth brands of Bristol-Myers. She has a 35 year career in the pharmaceutical and biotechnology business, combining ...

Corporate Headquarters

Connaught House
Dublin, Co. Dublin 4

Ireland

Phone: 353 1 772 8000
Fax: --

Board Members Memberships

2005-2010
Former Independent Director and Member of Human Resources Committee
2010-Present
Director, Member of Audit Committee and Member of Nominating & Corporate Governance Committee
2010-Present
Director, Member of Audit Committee and Member of Compensation Committee
2010-Present
Director, Chairman of Nominating & Governance Committee, Member of Audit Committee and Member of Compensation Committee
2011-Present
Director and Chairman of Nominating & Corporate Governance Committee
2011-Present
Director, Member of Nominating & Corporate Governance Committee and Member of Commercial Committee
2013-Present
Director, Member of Audit Committee and Member of Compensation Committee
2013-Present
Independent Director
2014-Present
Director and Member of Audit Committee

Education

MS
University of Cambridge
PhD
University of Cambridge
BS
University of Cambridge

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$89,000
Total Calculated Compensation$558,393
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
David M. Stack Chairman, Chief Executive Officer and President
Pacira Pharmaceuticals, Inc.
$1.0M
James A. Schoeneck Chief Executive Officer, President and Director
DepoMed Inc.
$620.1K
George Frederick Wilkinson Chief Executive Officer, President and Director
Impax Laboratories Inc.
$552.5K
Bruce C. Cozadd Co-Founder, Executive Chairman and Chief Executive Officer
Jazz Pharmaceuticals Public Limited Company
$830.0K
Daniel J. Abdun-Nabi Chief Executive Officer, President, Director, Member of Strategic Operations Committee and Member of Pricing Committee
Emergent BioSolutions, Inc.
$1.2M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Alkermes plc, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.